Dermatology
Sun Pharma and Philogen sign licence agreement for anti-cancer therapy
Sun Pharmaceutical Industries has reached a licence agreement with Philogen for the commercialisation of Philogen's Nidlegy (Daromun) in Australia, New…
FDA accepts Iovance’s BLA for melanoma therapy lifileucel
The US Food and Drug Administration (FDA) has accepted Iovance Biotherapeutics’ biologics license application (BLA) for lifileucel to treat advanced…
BSM supplies key component of Krystal Biotech’s DEB gene therapy
Berkshire Sterile Manufacturing (BSM) has supplied an excipient gel, a key component of Krystal Biotech’s gene therapy VYJUVEK, for dystrophic…
Boehringer receives breakthrough therapy designation for spesolimab
Boehringer Ingelheim has received breakthrough therapy designation (BTD) from the US Food and Drug Administration (FDA) for spesolimab (SPEVIGO) to…
Evommune gains funding to accelerate therapies for chronic inflammatory diseases
Evommune has received $50m in Series B financing to accelerate the development of therapies for the treatment of chronic inflammatory…
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Incyte receives EC approval for Opzelura to treat non-segmental vitiligo
Incyte has received marketing authorisation from the European Commission for Opzelura (ruxolitinib) cream 15mg/g to treat non-segmental vitiligo with facial…
MedX and PharmaChoice team up for teledermatology screening service
MedX Health Corporation has announced a Memorandum of Understanding for the launch of a pilot project with PharmaChoice Canada to…
US FDA accepts Arcutis’ NDA for seborrheic dermatitis therapy
The US Food and Drug Administration (FDA) has accepted Arcutis Biotherapeutics’ new drug application (NDA) for roflumilast foam 0.3% to…
Incannex engages QPS for CannQuit and ReneCann
Australian pharmaceutical company Incannex has appointed Quest Pharmaceutical Services (QPS) to advance CannQuit-N (Nicotine), CannQuit-O (Opioid) and Renecann Products in…
Zydus gets FDA approval for antibiotic drug azithromycin
The US Food and Drug Administration (FDA) has granted final approval to India-based Zydus Lifesciences' 500mg azithromycin tablets for the…